Latest Parkin Stories
A small protein called SUMO might prevent the protein aggregations that typify Parkinson's disease (PD), according to this study.
Parkinson disease (PD) affects 1-2% of the population over the age of 65 years.
--Two Clinical Trials and a Novel Biomarker Initiative for Parkinson's Disease-- MIAMI, June 30, 2011 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) has awarded more than $1 million dollars in clinical research projects in 2011.
Massachusetts General Hospital investigators appear to have found the mechanism behind a previously reported link between the rare genetic condition Gaucher disease and the common neurodegenerative disorder Parkinson's disease.
--Part of NPF's Quality Improvement Initiative-- MIAMI, June 23, 2011 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) and the Kinetics Foundation are pleased to announce their partnership to evaluate Kinetic's Objective Parkinson's Disease Measurement (OPDM) system as a tool for more accurately measuring the symptoms of Parkinson's disease (PD).
Researchers at the Keck School of Medicine of the University of Southern California (USC) have uncovered structural clues about the protein linked to Parkinson's disease (PD), which ultimately could lead to finding a cure for the degenerative neurological disorder.
Researchers at North Carolina State University have figured out how copper induces misfolding in the protein associated with Parkinson's disease, leading to creation of the fibrillar plaques which characterize the disease.
BRUSSELS, June 14, 2011 /PRNewswire/ -- A new study investigating the incidence and impact of gastrointestinal disorders (GID) among patients with Parkinson's disease (PD) found that patients who received both a PD diagnosis and a prior GID diagnosis appeared to have worse health outcomes compared to patients who received a diagnosis for PD with no prior GID diagnosis.
In a new study published today in the inaugural issue of the Journal of Parkinson's Disease, Israeli researchers report that by tracking pharmacy purchases of anti-Parkinson drugs they could estimate the number of Parkinson's disease (PD) cases in a large population.
Few treatments for Parkinson's disease (PD) restore function for extended periods.
- The parings of haberdine; also, any kind of fragments.